Vrdoljak E., Marschner N., Zielinski C., Gligorov J., Cortes J., Puglisi F., Aapro M., Fallowfield L., Fontana A., Inbar M., Kahán Zsuzsanna, Welt A., Lévy C., Brain E., Pivot X.:
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
ANNALS OF ONCOLOGY, 27 (11).
pp. 2046-2052.
ISSN 0923-7534
(2016)
|
Text
mdw316.pdf - Published Version Download (261kB) | Preview |
| Item Type: | Article |
|---|---|
| Journal or Publication Title: | ANNALS OF ONCOLOGY |
| Date: | 2016 |
| Volume: | 27 |
| Number: | 11 |
| Page Range: | pp. 2046-2052 |
| ISSN: | 0923-7534 |
| Faculty: | Faculty of Medicine |
| Institution: | Szegedi Tudományegyetem |
| SWORD language: | Angol |
| Identification Number: | 3257982 |
| DOI id: | https://doi.org/10.1093/annonc/mdw316 |
| Date Deposited: | 2017. Aug. 30. 11:19 |
| Last Modified: | 2017. Aug. 30. 11:19 |
| URI: | http://publicatio.bibl.u-szeged.hu/id/eprint/11866 |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics
